From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA move to restrict hydrocodone products could harm patients

from National Community Pharmacists Association

NCPA CEO B. Douglas Hoey issued a statement in response to news that the FDA is moving to reschedule hydrocodone-containing products from Schedule III to Schedule II. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063